Advertisement

Topics

Oncolytics Biotech Inc. Company Profile

01:39 EDT 25th March 2019 | BioPortfolio

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combination REOLYSIN® /radiation clinical trial in the U.K. The current clinical program includes local or systemic delivery of REOLYSIN® as a monotherapy, and local delivery of REOLYSIN® in combination with radiation therapy for patients with advanced cancers

Location

210, 1167 Kensington Crescent NW
Calgary
Alberta
T2N 1X7
Canada

Contact

Phone: 403.670.7377
Fax: 403.283.0858
Email: Info@oncolyticsbiotech.com


News Articles [1611 Associated News Articles listed on BioPortfolio]

New Collaboration For Oncolytics Biotech and SOLTI

On Monday (September 10), Oncolytics Biotech (NASDAQ:ONCY, TSX:ONC) announced details of its new collaboration for its Phase 3 clinical trial. The post New Collaboration For Oncolytics Biotech and SOL...

Oncolytics Biotech Appoints CMO

Dr. Rita Laeufle, M.D., Ph.D., had been working as a consultant for Oncolytics for the last four months

Oncolytics Biotech(R) to Host Conference Call to Discuss Year End Financial Results and Operational Highlights

CALGARY, AB and SAN DIEGO, CA / March 1, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announc.....

Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR

Data identifies a simple blood test that predicts clinical response to pelareorep CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / February 27, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC).....

Oncolytics Biotech Collaborates with SOLTI to Conduct a Window of Opportunity Study in Breast Cancer with Pelareorep

Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced a clinical col...

Oncolytics Biotech Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS Mutant Metastatic Colorectal Cancer for Presentation at ESMO 2018

CALGARY, Alberta and SAN DIEGO, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic vir...

Oncolytics Biotech Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln Park Capital

Oncolytics Biotech (NASDAQ:ONCY,TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced the execution of a Common Stock P...

Oncolytics Biotech: Focusing its Trials

Dr. Brad Thompson, CEO of Oncolytics Biotech talks through the solid science that underpins his company. Whilst describing the company’s story to date he discusses overcoming the regulatory hurdles ...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Prestalia [marina biotech]

These highlights do not include all the information needed to use PRESTALIA tablets safely and effectively. See full prescribing information for PRESTALIA.PRESTALIA (perindopril arginine and amlodipin...

Pyridostigmine bromide [rising pharmaceuticals, inc.]

Pyridostigmine Bromide Extended-Release Tablets, 180 mg

Vivotif-b [rebel distributors corp]

Vivotif-B

Stelara [janssen biotech, inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) injection, for subcutaneous or int...

Ctx4 gel 5000 [oral biotech]

CariFree® CTx4 Gel 50001.1% (w/w) sodium fluoride

PubMed Articles [19 Associated PubMed Articles listed on BioPortfolio]

Third-quarter biotech job picture.

New Nonprofit Biotech From Bill and Melinda Gates.

Biotech leaders call for free press.

US law threatens flow of foreign capital to biotech sector.

Genetic data sharing: a new type of capital.

Over the last three decades, various biotech companies, mostly in North America, have become experts in the production, processing and analysis of large volumes of genetic data. They have surpassed th...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

The Validation of a Novel Adherence Method for Oral Oncolytics

The long-term goal of this research is to apply technologic approaches to improve the use of oral oncolytics. The objective of this study is to assess patient adherence to oral oncolytics ...

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

This phase I clinical study was designed to evaluate the safety of Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type)(E.Coli)(hereafter called HPV vaccine), manufact...

Companies [939 Associated Companies listed on BioPortfolio]

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

Nascent Biotech, Inc.

Nascent Biotech, Inc is a clinical-stage biotech company engaged in the development of monoclonal antibodies to be used in the treatment of various cancers. Its products are not c...

More Information about "Oncolytics Biotech Inc." on BioPortfolio

We have published hundreds of Oncolytics Biotech Inc. news stories on BioPortfolio along with dozens of Oncolytics Biotech Inc. Clinical Trials and PubMed Articles about Oncolytics Biotech Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oncolytics Biotech Inc. Companies in our database. You can also find out about relevant Oncolytics Biotech Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record